Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Scheduling (national classification system) (166)
- Committees and advisory bodies (384)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
166 result(s) found, displaying 151 to 166
-
Scheduling submissionsPublic submissions on interim scheduling decisions for substances referred to the November 2017 ACMS/ACCS meetings are now available
-
Scheduling decisions (final)Final decisions for substances referred to the ACMS, ACCS/ACMS, ACCS November 2017 meetings, and delegate only decisions on agricultural and veterinary chemicals and NCEs.
-
Scheduling submissionsPublic submissions on matters referred to the March 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2018 -
Scheduling decisions (final)Scheduling delegates' final decisions: NCEs, January 2017 now published
-
Scheduling decisions (final)Final decisions and reasons for matters referred to ACCS#20, ACMS #21 (July 2017 meetings) and Joint ACCS-ACMS #15 and #16 (March and July 2017meetings).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 October 2017
-
Scheduling decisions (final)Final decisions for medicines and chemicals referred to March 2017 scheduling meetings (ACMS #20, ACCS #19 and Joint ACMS-ACCS #15) and NCEs.
-
Scheduling decisions (final)New Chemical Entity (NCE) delegate's final decision and reasons for decision for brexpiprazole
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 31 May 2017
-
Scheduling decisions (final)Delegate-only final decisions to amend the Poisons Standard not referred to an expert advisory committee.
-
Corporate reportsRegulation impact statement: Codeine re-scheduling
-
Scheduling decisions (final)Q&A about changes to the scheduling of codeine.
-
Corporate reportsEconomic modelling and financial quantification of the regulatory impact of proposed changes to codeine scheduling
-
Corporate reportsThe Scheduling Policy Framework (SPF) is a key feature of the revised arrangements for scheduling of medicines and chemicals
-
Corporate reportsThe NCCTG Scheduling Policy Framework outlines how medicines and chemicals are classified and regulated in Australia to support safe and consistent decision-making.